China conditionally approves four self-developed COVID-19 vaccines: official
Xinhua |
Updated: 2021-02-26 20:09
Share
Share - WeChat
BEIJING - China has granted conditional market approval to four self-developed COVID-19 vaccines, Minister of Science and Technology Wang Zhigang said Friday.
China has adopted five technological approaches in developing COVID-19 vaccines. China now has 17 self-developed COVID-19 vaccines undergoing clinical trials, with seven undergoing phase-3 clinical trials, Wang told a press conference held in Beijing.
China has also included 11 drugs and treatment methods in its diagnosis and treatment plan for COVID-19, Wang added.
- American musician: the Silk Road influenced American music
- China upgrades Ragasa to super typhoon
- Over 5,000 photographers showcase work in Shanxi's ancient city of Pingyao
- Li calls on US lawmakers to enhance exchanges, ties
- Luxury brands drop ads featuring S. Korean actress after she insults China
- Jiangmen activates Chikungunya fever L3 emergency response
